AI4Cancer

About Us

Here's what we can do for you

Requirements

Published in a peer-reviewed journal

Externally validated (unless it is based on a large number of patients and/or it concern a rare disease)

Clinically Relevant

Costs

Absolutely zero costs, as AI4cancer is a fully open-source project

What's in it for you?

Increased visibility, utilization and citation of your paper

International impact

“Open Source Approach” is encouraged & requested by grant funding bodies.

Process

How does it work?

Step 1

Let's Go

Step 2

Create a new model by providing information about it from our wizard.

Step 3

Complete the creation of new model by uploading all the regression coefficients of the model, including the coefficient of the intercept.

Step 4

Provide the pubmed link for your model

Step 5

We will review your model and publish it on the AI4Cancer application.

Step 6

And it's Done! your model will be published at Ai4Cancer!

Acknowledgements

Euradiomics

The development of the decision support models in this online platform was made possible with the financial support of the Interreg EMR programme through the collaboration in the Euradiomics project. The total budget for the project is € 3.402.970,70 and Interreg is contributing € 1.701.485,35.

The Interreg V-A Euregio Meuse-Rhine (EMR) programme invests almost EUR 100 million in the development of the Interreg-region until 2020. This area stretches out from Leuven in the west to the borders of Cologne in the east and runs from Eindhoven in the north all the way down to the border of Luxemburg. Over 5.5 million people live in this cross-border region, where the best of three countries merges into a truly European culture.

With the investment of EU funds in Interreg projects, the European Union directly invests in the economic development, innovation, territorial development and social inclusion and education of this region.

Interreg EMR Program

Partners

Contact

Get in touch with us!

What is Ai4Cancer?

AI4Cancer is intended for open source publishing of prediction models, developed to predict outcomes for cancer patients. Once a year, if the author agrees, the models available in the website are transferred to our free application as well!